SFI
HGEN

Susquehanna Fundamental Investments’s HUMANIGEN, INC. HGEN Stock Holding History

Susquehanna Fundamental Investments’s Portfolio HGEN Stock Details HGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-43,575
Closed -$8K – 1576
2022
Q3 		$8K Buy
+43,575
New +$23.4K ﹤0.01% 1421
2022
Q1 		$131K Hold
43,575
– – ﹤0.01% 1431
2021
Q4 		$162K Buy
+43,575
New +$255K ﹤0.01% 1285
2021
Q3 		– Sell
-34,495
Closed -$600K – 1948
2021
Q2 		$600K Sell
34,495
-3,507
-9% -$63.9K 0.01% 1081
2021
Q1 		$726K Buy
38,002
+500
+1% +$9.13K 0.01% 1005
2020
Q4 		$656K Buy
+37,502
New +$449K 0.01% 997

Other funds holding HGEN

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Susquehanna Fundamental Investments's HGEN Position: Q4 2022 in Review

Susquehanna Fundamental Investments sold out of HUMANIGEN, INC. (HGEN) in Q4 2022, closing a stake of 43,575 shares — an estimated $8K sold.

Susquehanna Fundamental Investments first reported a position in HGEN in Q4 2020 and held it in 6 quarters. The position peaked at $726K in Q1 2021. 48 funds tracked by Wall St. Rank hold HGEN as of Q4 2022.

  • Susquehanna Fundamental Investments reported no remaining HUMANIGEN, INC. position as of Q4 2022 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 43,575 HUMANIGEN, INC. shares in Q4 2022, an estimated $8K.
  • Susquehanna Fundamental Investments first reported a position in HUMANIGEN, INC. in Q4 2020 and held it in 6 quarters.
  • Susquehanna Fundamental Investments's HUMANIGEN, INC. position peaked at $726K in Q1 2021.
  • 48 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q4 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2022, filed 14 Feb 2023.